Blog

Deal reviews that move deals, not just review them

Your deal review is theatre unless you focus on economic buyers, champion risk, and what the rep will actually do Monday morning.

Published 12 October 2026

Your deal review becomes theatre the moment it turns into a status check. Manager asks "where are we," rep recites the stage, nobody surfaces the real problem. Three hours later, the deal sits where it was.

A deal review that moves deals forward has one job: surface what's actually blocking close, then arm the rep with a concrete next move. The difference is structural.

Focus the conversation on the economic buyer and champion, not the deal stage

You're not reviewing where a deal sits in your pipeline. You're reviewing who needs to buy and whether they're actually aligned. Economic buyer is the person who controls the budget and makes the final yes-or-no. Champion is the person inside the account who has incentive to see your solution win.

When you run a deal review, start here: "Walk me through the economic buyer. What's their biggest constraint right now—timeline, budget, risk, politics? How do we know?" If the rep cannot name the constraint without guessing, you've found your blocking issue. The rep doesn't have access. The champion isn't secure enough to share it. The deal isn't real yet.

Same for champion risk. "If your champion leaves tomorrow, does the deal die?" Most reps will hesitate. If they say yes, the review is over. You're building a second thread into the account before anything else happens. If they say no, ask them to name the second person who will push for you. If they can't, you're still at risk.

Buying committee size is now averaging 10–11 stakeholders in B2B. You cannot close this deal through one person. Your review should map: economic buyer, champion, technical evaluator, CFO, whoever else holds veto power. And for each person, the rep should know their actual constraint, not the generic one.

Ask what the rep will do Monday morning, not what they've already done

Deal reviews live in the past tense. "What have we done?" is a backward question. Deals move when you ask forward questions.

"What is the rep doing this week to move the deal?" It should be specific enough that you could walk behind the rep's desk and see evidence of it. Not "building a business case." That's still vague. "Building a business case showing payback in 14 months versus the 18-month timeline their CFO mentioned" is specific. You can coach on that.

Or: "Which stakeholder needs a conversation this week, and why?" If the rep says "we're waiting to hear from them," that's passive. You're not waiting. The rep is doing something to force a response. Maybe it's a message that creates urgency. Maybe it's pulling the conversation into a group setting so silence becomes awkward. Maybe it's changing channels—moving from email to a real-time meeting. The point is the rep has agency.

Build a weekly motion into every deal review, not a quarterly forecast. "By Friday, you will have done X with Y stakeholder, and you'll know Z." Specificity makes accountability possible.

Uncover the real obstacle, not the stated one

Reps rarely volunteer the real reason a deal isn't closing. They give you the plausible reason. "They need internal alignment" is plausible. It's also useless. What kind of alignment? Between whom? What's the actual concern underneath?

Push twice as deep as feels natural. "Internal alignment—what does that actually mean?" Pause. Let them sit with it. They'll usually say something more honest: "The ops team thinks we're overbuilding. The CTO wants more features than they need." Now you're working with real information.

Same pattern with "we need to think about it." Ask: "What are they actually thinking about? What's the decision that's sitting in front of them right now?" The rep either knows or doesn't. If they don't, that's the action item: go find out.

Real obstacles come with names and timelines. "Sarah in procurement needs us to hit their Q1 budget window, and it's December 15th—if we miss it, the deal slides to Q1." That's real. You can work with it. "They need to think about it" is static. It stops momentum.

The deal review output is a single next step with a timeline

At the end of your review, the rep should walk out with one thing they're doing before you talk again. Not a list. One thing.

Not "multithread the buying committee." That's a theme. "Set a meeting with the economic buyer and your champion together by Wednesday so we can hear directly what the budget constraint is." That's an action with a date.

The action should be risky enough that the rep will feel it if they don't do it. "Send a follow-up email" is not risky. The rep can do it without thinking. "Call the champion today and ask whether the deal has real urgency this quarter or if we should plan for Q1" is risky. It opens a door that might close. That's what moves deals.

Review the action in your next 1-on-1. Not "did you do it"—that's a yes-or-no. But "what happened when you called?" The rep's answer tells you whether the obstacle is real or imagined, whether your champion is actually secure, whether you're still in the deal at all.

The difference between theatre and actual deal progression

Theatre sounds like: "We're in the evaluation stage, waiting for them to run their POC, should close in January." Thirty days later, same story. The rep has been passive, the deal hasn't moved, your forecast was fiction.

Actual deal progression sounds like: "The champion confirmed the POC window is two weeks. I'm setting up a kickoff call with the technical lead on Thursday. By next week, I need to understand whether the ops team actually has bandwidth to run it, or whether we're looking at February instead." When you follow up, the rep has concrete information. The deal either moves or dies. Both are progress.

Deal reviews that move deals are uncomfortable. They force clarity where reps prefer ambiguity. But that clarity is what closes deals. You're not reviewing a deal. You're unblocking one.

Common questions

What's the difference between a champion and an economic buyer?

An economic buyer controls the budget and makes the final yes-or-no decision. A champion has internal influence and incentive to see your solution win, but may not hold budget power. You need both aligned; losing the champion kills momentum, losing the economic buyer kills the deal.

How do you know if a deal is actually at risk from champion turnover?

Ask the rep: 'If your champion leaves tomorrow, does the deal die?' If they hesitate or say yes, you're at risk. Then ask them to name a second stakeholder who will push for you. If they can't, immediately start building a second thread before it's too late.

How often should you run deal reviews?

Weekly for deals in the last 30 days before close. Monthly for deals earlier in the cycle. Frequency should match velocity. Deals that aren't moving need weekly pressure; stable deals need monthly checkpoints. The review should always produce one specific action for the rep to complete before the next one.

Why is 'we're waiting to hear back' a red flag in deal reviews?

Waiting is passive. It means the rep is not in control. Real deals move when the rep creates urgency, changes channels, brings stakeholders together, or asks a forcing question. If the rep is waiting, they're not closing—they're hoping.

What should you ask when a rep says a deal needs 'internal alignment'?

Push deeper: 'What kind of alignment? Between whom? What's the actual disagreement underneath?' Usually it surfaces something real—a team thinks you're overbuilding, a stakeholder has budget concerns, or there's political risk. Real obstacles have names and timelines; vague ones mean the rep hasn't done their work.

Sources

Coaching that arrives during the call, not after it

Repwing listens to your discovery calls and puts the next question on your phone while you are still in the conversation. Fourteen days free, no card.

Start free trial